Related Experiment Video
Updated: Jan 28, 2026

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli
Published on: August 3, 2017
Fed-batch strategies for the enhanced biotransformation of cis-epoxysuccinate to L-( +)-tartrate
Jia-Jun Ouyang1,2,3, Jiang Pan1, Jian-He Xu4
1State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China.
Abstract:
L-( +)-Tartaric acid is a valuable organic acid with broad applications in the food, pharmaceutical, and chemical industries. Its eco-friendly synthesis typically relies on the enzymatic hydrolysis of cis-epoxysuccinate (CES) catalyzed by cis-epoxysuccinate hydrolases (CESHs), but conventional single-batch processes suffer from low space-time yields and poor continuity. To address these challenges, we devised two complementary fed-batch strategies to simplify the enzyme-product separation by exploiting differences in their solubilities. Strategy A employs carrier-free cross-linking immobilization of whole cells using 0.02% glutaraldehyde and 0.1% polyethylenimine. In this system, both the substrate sodium cis-epoxysuccinate (CESNa) and the product sodium L-( +)-tartrate remain soluble, while the enzyme is retained in the insoluble cell matrix. Under fed-batch operation, this configuration achieves a space-time yield of 150 g L-1 h-1. Strategy B uses cell-free extract of CESH to hydrolyze calcium cis-epoxysuccinate (CESCa) with inherently low solubility. Here, the enzyme is fully soluble but the L-( +)-tartrate formed precipitates as an insoluble calcium salt, allowing easy separation of the product from the reaction mixture. This approach overcomes potential substrate inhibition and minimizes sodium-ion discharge, delivering a space-time yield of 136 g L-1 h-1 and a specific productivity of 484 gproduct/gcatalyst. Both the soluble-product/insoluble-enzyme system (A) and the insoluble-product/soluble-enzyme system (B) represent effective strategies to streamline downstream processing and markedly enhance productivity. Together, they offer a viable route to scalable and cost-effective industrial production of L-( +)-tartaric acid.
Related Concept Videos
Cis-regulatory Sequences
Cis-regulatory Sequences
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Self-Evaluation: Self-Enhancement and Self-Verification

